Immediate Impact
3 from Science/Nature 50 standout
Citing Papers
Advances in nanoparticles in targeted drug delivery–A review
2025 Standout
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Works of Laura Todi being referenced
Human Leukocyte Antigen Class II associations in late‐onset Myasthenia Gravis
2021
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Laura Todi | 17 | 58 | 41 | 76 | 43 | 17 | 270 | |
| Amichai Schattner | 30 | 109 | 26 | 18 | 23 | 17 | 274 | |
| G. Riethmüller | 19 | 148 | 25 | 44 | 12 | 16 | 284 | |
| L. Musset | 24 | 39 | 20 | 144 | 52 | 16 | 332 | |
| Ming Chao | 8 | 28 | 17 | 43 | 40 | 19 | 235 | |
| Naotake Sato | 25 | 62 | 10 | 34 | 11 | 11 | 197 | |
| Sanyun Wu | 4 | 26 | 44 | 24 | 48 | 20 | 277 | |
| Maria Luigia Vigliotti | 11 | 68 | 14 | 18 | 73 | 16 | 300 | |
| Massimo Devani | 74 | 37 | 30 | 21 | 10 | 21 | 261 | |
| Cristiane Milito | 13 | 46 | 9 | 34 | 18 | 26 | 298 | |
| H J Plüss | 23 | 73 | 19 | 25 | 12 | 15 | 311 |
All Works
Login with ORCID to disown or claim papers
Loading papers...